24.03.2021     08:00–19:30

ePoster self study
Innate immunity
ePoster self study


ePoster self study
Innate immunity
ePoster self study

P 102 The M35 protein of MCMV directly binds the regulatory DNA element that controls IFNB1 transcription
Hella Schwanke (Braunschweig/DE)

P 103 Impaired production of TNF-α, IL-1β, IL-8 and IL-17 in HIV-infected individuals with Tuberculosis
Marina Nosik (Moscow/RU)

P 104 Differential upregulation of antiviral and proinflammatory cytokines in Nipah virus infected human airway epithelial cells
Kathleen Voigt (Marburg/DE)

P 105 Effect of Rubella Virus infection on RIG-I and MDA5, key elements of the innate immune response
Esther Behrsing (Berlin/DE)

P 106 The influenza A virus (IAV) non-structural protein NS1 effector domain is sufficient to trigger host shutoff by mediating transcriptional inhibition in the absence of any other viral function when locatalised in nuclear speckle like structures
Wolfgang Nacken (Münster/DE)

P 107 Analysis of Toll-like receptor activation in rubella virus-infected immune cells
Eva Gabriel (Berlin/DE)

P 108 Delivery of toll-like receptor 3 Ligand Poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an Anti-Hepatitis B Virus effect in a mouse model
Yanqin Du (Essen/DE)

P 109 Convergent evolution of HIV-1- and HIV-2-mediated HLA-C downmodulation
Kristina Hopfensperger (Tübingen/DE)

P 110 Characterization of the role of murine 2"-5"-oligoadenylate synthetase-like protein 2 (mOASL2) in murine gammaherpesvirus-68 (MHV68) infection
Viktoria Vögele (Braunschweig/DE)

P 111 Towards the innate immunity phenotype of newly emerging viruses
Ulrike Felgenhauer (Gießen/DE)

P 112 LGP2 is essential for IFN induction and viral suppression during hepatitis D virus infection and the natural Q425R LGP2 variant exhibits stronger antiviral activity
Nadine Gillich (Heidelberg/DE)

P 113 Type III IFNs act efficiently in a paracrine manner to prevent the spread of rotavirus in intestinal epithelial cells
Patricio Doldan (Heidelberg/DE)

P 114 A human cytomegalovirus (HCMV)-encoded glyco-protein, RL11/gp34, antagonizes CRP-activation of FcγRI/CD64
Anna Henning (Freiburg/DE)

P 115 Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus
Mirco Glitscher (Langen/DE)

P 116 How pestiviruses modulate the innate immune system - comparison of different Erns
Elena De Martin (Bern/CH)

P 117 Acute IFNAR1 signaling determines murine gamma herpesvirus 68 infected cell density in vivo
Razieh Zargari (Hannover/DE)

P 118 Metabolic requirements of NK cells during the response against retroviral infection
Elisabeth Littwitz-Salomon (Essen/DE)

P 119 High resolution kinetic characterization of the RIG-I signaling pathway and the subsequent antiviral responses
Sandy Burkart (Heidelberg/DE)

P 120 Innate immune evasion by pestiviral Erns in bovine airway epithelial cell cultures
Guillaume Beilleau (Bern/CH)

P 121 Transient synergetic effect of IL-22 enhances antiviral activity of IFN-l in human intestinal cells
Cuncai Guo (Heidelberg/DE)

P 122 MAVS is needed for the induction of IFN-β responses in VSV infected neurons, astrocytes and microglia
Olivia Luise Gern (Hannover/DE)

P 123 The transcription factor BATF as modulator of type I interferon expression in plasmacytoid dendritic cells
Stefanie Scheu (Düsseldorf/DE)

P 124 Determinants of hepatitis C virus (HCV) resistance to interferon (IFN)
Nicola Frericks (Hannover/DE)

P 125 Cooperation of  MAPKAP kinases 2 and 3 supports viral replication and cytokine responses upon CMV infection and abbreviates transient appearance of CD11b+ myeloid-cell aggregates with CD8+ T cells
Christian Ehlting (Düsseldorf/DE)

P 126 Deciphering the role of the IRF family members in innate immunity during early viral infection
Sandra Wüst (Heidelberg/DE)

P 127 Role of the human cytomegalovirus effector protein IE1 as antagonist of necroptotic cell death
Anna Theresa Heusel (Ulm/DE)

P 128 Npro of Atypical porcine pestivirus (APPV) fails to antagonize the IFN induction pathway
Susanne Koethe (Greifswald-Insel Riems/DE)

P 129 Inhibition of early stage HCMV infection by designing small molecule inhibitors targeting the HCMV UL35-UL82 complex
Ramya Ramani (Braunschweig/DE)

P 130 Impact of reported mutations in SAMHD1 on DNA replication
Catharina Majer (Langen/DE)

P 131 Increased IFNγ levels through CMV replication in combination with NKG2Cpos NK cells likely contribute to a reduced AML relapse risk after HSCT
Wiebke Moskorz (Düsseldorf/DE)

P 132 TLR3 activation reduces interferon response in STAT3/SOCS3-dependent manner during Zika virus infection
Agnieszka Plociennikowska (Heidelberg/DE)

P 133 IFN-k suppresses SARS-CoV-2 infection
Vladimir G. Magalhaes (Heidelberg/DE)